Unicycive Therapeutics, Inc.UNCYNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank29
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-20.68M
↓ 45% vs avg
Percentile
P29
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-14.30M
Historical baseline
PeriodValueYoY Change
TTM$-20.68M+42.9%
2024$-36.23M-20.1%
2023$-30.18M-68.7%
2022$-17.89M-90.8%
2021$-9.38M-
2020$0.00+100.0%
2019$-63000.00-
2018$0.00-